Mark A. Moyad, MD, MPH & Martin M. Miner, MD, discuss the potential benefits of semaglutide, a newly approved weight-loss drug. Semaglutide is a medication that has been approved by the FDA to treat type 2 diabetes and has also been approved for obesity management under the brand name Wegovy...
ABSTRACT Several pharmacological approaches to controlling body weight have been developed over the last decades, albeit with limited success. Currently, available agents include centrally-acting appetite suppressants and peripherally acting compounds. The efficacy and safety of these agents...
No mention in the slides of keeping insulin low. Insulin is one of the most-potent cancer promoters. I suggest people interested in this topic read The Metabolic Approach to Cancer by Dr. Nasha Winters for a more comprehensive look at this topic.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.